- DATE: Tues, 1/18/11
- TIME: 5:30-7:00PM
- WHERE: Rutgers University, Piscataway, NJ
As part of the Rutgers genetic study of Tourette Syndrome, Robert A. King, MD will present recent clinical advances in medication and other state-of-the-art treatments for Tourette Syndrome and associated conditions. Gary Heiman, PhD will present information on genetics of Tourette Syndrome and describe Rutgers’ ongoing genetic research study. The presentations will be followed by a Q&A session and refreshments will be provided.
Dr. King is Medical Director of the Tourette’s/OCD/Anxiety Disorder Clinic at the Yale Child Study Center, where he is also Professor of Child Psychiatry. He is the author of numerous scientific papers and textbook chapters on Tourette’s and related disorders and is the author of the American Academy of Child and Adolescent Psychiatry’s Practice Parameter on Assessment and Treatment of Childhood OCD.
Dr. Heiman is an Assistant Professor at Rutgers University and the Directory of the New Jersey Center for Tourette Syndrome Sharing Repository; a cell and DNA repository for Tourette Syndrome and associated disorders. This study seeks to identify genetic factors that affect the liability toward developing Tourette Syndrome, chronic tics, and related clinical entities including obsessive compulsive disorder.
Space is limited. For more information, directions and to reserve your seat, email (email@example.com) us and 1) leave your name, 2) phone number and 3) how many people will attend. Families are welcome. Registration is free but mandatory. Deadline for reserving a seat is 1/10/11.